Furthermore, i.c.v. injection of MCLs blocked beneficial effects of (R)-ketamine on depression-like phenotypes, reduced ratio of p-CREB/CREB, reduced expression of BDNF and increased expression of MeCP2 in the mPFC of CSDS susceptible mice. This evidence concerns the gene BDNF and depressive symptom measurement.